- Home
- TMDX vs VRNS Comparison
TMDX vs VRNS Comparison
Compare TMDX & VRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TMDX | VRNS |
|---|---|---|
| Founded | 1998 | 2004 |
| Country | United States | United States |
| Employees | N/A | 2658 |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.3B |
| IPO Year | 2019 | 2013 |
Fundamental Metrics
Financial Performance| Metric | TMDX | VRNS |
|---|---|---|
| Price | $67.93 | $28.39 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 21 |
| Target Price | ★ $148.22 | $42.75 |
| AVG Volume (30 Days) | 1.2M | ★ 2.7M |
| Earning Date | 05-05-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 382.18 | N/A |
| EPS | ★ 0.20 | N/A |
| Revenue | ★ $605,494,000.00 | $270,288,000.00 |
| Revenue This Year | $24.25 | $18.87 |
| Revenue Next Year | $18.75 | $17.77 |
| P/E Ratio | $362.75 | ★ N/A |
| Revenue Growth | ★ 37.13 | 24.35 |
| 52 Week Low | $70.00 | $19.70 |
| 52 Week High | $156.00 | $63.90 |
Technical Indicators
Market Signals| Indicator | TMDX | VRNS |
|---|---|---|
| Relative Strength Index (RSI) | 19.80 | 67.90 |
| Support Level | N/A | $20.21 |
| Resistance Level | $131.86 | $28.99 |
| Average True Range (ATR) | 5.31 | 1.45 |
| MACD | -3.88 | 0.37 |
| Stochastic Oscillator | 0.17 | 79.88 |
Price Performance
Historical ComparisonAbout TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
About VRNS Varonis Systems Inc.
Varonis Systems is a cybersecurity vendor focused on data privacy and security. The firm is currently undergoing a cloud transition as it weans its on-premises customers over to its cloud products that are delivered as software-as-a-service. The New York-based firm was founded in 2005 and went public in 2014.